[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Mereo BioPharma's Setrusumab Phase III trial data is highly anticipated, with recent posts highlighting strong patient retention in OLE studies and positive analyst outlooks, despite some concerns about dilution.
Mereo BioPharma is a biopharmaceutical company focused on developing innovative therapeutics.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX +62%
X Month: XXXXXXX +59%
X Months: XXXXXXXXX -XXXX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-07-10
1-Year Low: XXX on 2025-11-09
Engagements by network (24h): Reddit: X X: XXXXXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
X Week: XXX +117%
X Month: XXX +27%
X Months: XXXXX +50%
X Year: XXXXX +42%
1-Year High: XXX on 2025-01-22
1-Year Low: XX on 2025-09-21
Mentions by network (24h): Reddit: X X: XXXXX
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $mreo in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX +71%
X Month: XXX +19%
X Months: XXXXX +211%
X Year: XXXXX +181%
1-Year High: XXX on 2025-06-29
1-Year Low: XX on 2025-09-24
The most influential creators that mention $mreo in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Pharmdca | X | XXXXXXX | X | XXXXX |
| @Heatlamp11 | X | XXX | XX | XXXXX |
| @ej23ny | X | XXXXX | XX | XXX |
| @QuantEmperor | X | XXXXX | X | XXX |
| @TedKaridis | X | XXX | X | XXX |
| @AponiaAnalytics | X | XXXXX | X | XXX |
| @PatientMan16079 | X | XX | X | XXX |
| @semodough | X | XXXXXX | X | XXX |
| @JeffNNNG | X | XX | X | XXX |
| @FeldtInvesting | XX | XXX | XX | XXX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -X%
X Year: XX% -X%
1-Year High: XXX% on 2025-02-21
1-Year Low: XX% on 2025-04-10
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$mreo Noticed regional / city specific Senior MSL and UCL roles opened by Ultragenyx for OI. UCL roles are X weeks old and MSLs have been opened in the last 3-5 days. Guess Rare still believes the drug is likely to make it to patients. DB lock should be soon if not already done"
X Link @bioluck80 2025-12-13T01:31Z XX followers, XX engagements
"$MREO & $RARE The following from A.I. in quotes is regarding how positive the information RARE discussed today at the CANTOR meeting describes the exceptionally high turnover from Cosmic & Orbit patients' enrollment into OLE "99% of the time very high OLE enrollment in a rare pediatric bone disease is a good sign and correlates with ultimate success. Setrusumabs OLE uptake (reported as very high for nearly all eligible patients is legitimately bullish and pushes the probability of success higher (most people now quote a 7090% chance of hitting the Phase X endpoints).""
X Link @Heatlamp11 2025-12-12T20:55Z XXX followers, XXX engagements
"** HIGHEST IMPLIED VOLATILITY OPTIONS ** $META $TERN $MREO $LAZR $NFE $RVPH $ALDX $MRNA $ALT $APLT $BZFD $ABVE $NXDR $IRBT $CGC $TTD"
X Link @QuantEmperor 2025-12-12T20:45Z 2118 followers, XXX engagements
"$MREO - Tigit is DOA. Well at least we have Etigilimab. DSK in partnering discussions as we speak.🤣"
X Link @TedKaridis 2025-12-12T19:57Z XXX followers, XXX engagements